Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists

被引：42
作者：
Carroll, William A.
Kalvin, Douglas M.
Medranoa, Arturo Perez
Florjancic, Alan S.
Wang, Ying
Donnelly-Roberts, Diana L.
Namovic, Marian T.
Grayson, George
Honore, Prisca
Jarvis, Michael F.
机构：
[1] Abbott Labs, Neurosci Res, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Med Chem Technol, Abbott Pk, IL 60064 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 14期
关键词：
P2X(7) antagonist; neuropathic pain;
D O I：
10.1016/j.bmcl.2007.04.075
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Structure-activity relationship (SAR) studies were conducted around early tetrazole-based leads 3 and 4. Replacements for the tetrazole core were investigated and the pendant benzyl substitution was reoptimized with a triazole isostere. Triazole-based P2X(7) antagonists were identified with similar potency to the lead compound 4 but with improved physiochemical properties. Compound 12 was active in a rat model of neuropathic pain. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4044 / 4048
页数：5
相关论文
共 25 条
[1]   Novel P2X7 receptor antagonists [J].
Alcaraz, L ;
Baxter, A ;
Bent, J ;
Bowers, K ;
Braddock, M ;
Cladingboel, D ;
Donald, D ;
Fagura, M ;
Furber, M ;
Laurent, C ;
Lawson, M ;
Mortimore, M ;
McCormick, M ;
Roberts, N ;
Robertson, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) :4043-4046
[2]   Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor [J].
Baraldi, PG ;
Nuñez, MD ;
Morelli, A ;
Falzoni, S ;
Di Virgilio, F ;
Romagnoli, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1318-1329
[3]   Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor [J].
Baraldi, PG ;
Romagnoli, R ;
Tabrizi, MA ;
Falzoni, S ;
Di Virgilio, F .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (07) :681-684
[4]   Hit-to-lead studies:: The discovery of potent adamantane amide P2X7 receptor antagonists [J].
Baxter, A ;
Bent, J ;
Bowers, K ;
Braddock, M ;
Brough, S ;
Fagura, M ;
Lawson, M ;
McInally, T ;
Mortimore, M ;
Robertson, M ;
Weaver, R ;
Webborn, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) :4047-4050
[5]   Functionalized congeners of tyrosine-based P2X7 receptor antagonists:: Probing multiple sites for linking and dimerization [J].
Chen, WZ ;
Ravi, RG ;
Kertesy, SB ;
Dubyak, GR ;
Jacobson, KA .
BIOCONJUGATE CHEMISTRY, 2002, 13 (05) :1100-1111
[6]   Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain [J].
Chessell, IP ;
Hatcher, JP ;
Bountra, C ;
Michel, AD ;
Hughes, JP ;
Green, P ;
Egerton, J ;
Murfin, M ;
Richardson, J ;
Peck, WL ;
Grahames, CBA ;
Casula, MA ;
Yiangou, Y ;
Birch, R ;
Anand, P ;
Buell, GN .
PAIN, 2005, 114 (03) :386-396
[7]  
Di Virgilio F, 2001, HANDB EXP PHARM, V151, P355
[8]   ALKYLATION OF IMIDAZOLE BY SOLID-LIQUID PHASE-TRANSFER CATALYSIS IN THE ABSENCE OF SOLVENT [J].
DIEZBARRA, E ;
DELAHOZ, A ;
SANCHEZMIGALLON, A ;
TEJEDA, J .
SYNTHETIC COMMUNICATIONS, 1993, 23 (13) :1783-1786
[9]   The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes [J].
Gargett, CE ;
Wiley, JS .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (08) :1483-1490
[10]   ATP-gated P2X channels [J].
Girdler, G ;
Khakh, BS .
CURRENT BIOLOGY, 2004, 14 (01) :R6-R6
123